|
EP3700509A1
|
|
Color stable fixed dose tablet combination of ibuprofen and paracetamol
|
|
EP3644968A1
|
|
Levocloperastine fendizoate suspension having enhanced dissolution and resuspendability
|
|
WO2018208242A1
|
|
Formulation of deferasirox tablet for oral suspension composition with better processability
|
|
WO2018208241A1
|
|
Formulation and optimization of controlled release tablets of morphine sulphate
|
|
EP3600275A1
|
|
Stabilized pharmaceutical syrup composition comprising terbutaline sulphate and ambroxol hydrochloride
|
|
WO2018169497A1
|
|
Spray formulation comprising cholecalciferol (vitamin d3) with improved stability
|
|
WO2018034626A1
|
|
Antiparkinson tablet formulation with improved dissolution profile
|
